Bliss GVS Pharma Ltd. NSE: BLISSGVS | BSE: 506197

Strong Performer, Under Radar

Download real time

154.84 1.68 (1.10%)

46.02% Gain from 52W Low

122.8K

NSE+BSE Volume

NSE 15 Jul, 2025 11:49 AM (IST)

Dividend

Bliss GVS Pharma Ltd. has an upcoming dividend of ₹0.50 per share due on 24 Jul 2025 See details

Bliss GVS Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bliss GVS Pharma Ltd. on BSE

Search Inside the pdf :

Bliss GVS Pharma Ltd.

10 Jul 2025

154.84

1.10%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith Newspaper Advertisement of Notice of 40th Annual General Meeting, e-voting and Book Closure Information.

Bliss GVS Pharma Ltd.

09 Jul 2025

154.84

1.10%

Corp. Note

Bliss GVS Pharma Ltd - 506197 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Please find enclosed herewith the Business Responsibility and Sustainability Report for the FY 2024-2025.

Bliss GVS Pharma Ltd.

09 Jul 2025

154.84

1.10%

AGM

Bliss GVS Pharma Ltd - 506197 - Notice Of The 40Th Annual General Meeting ('40Th AGM') …

BSE India

Please find enclosed herewith the Notice of the 40th AGM of Bliss GVS Pharma Limited ("the Company") scheduled to be held on Thursday, July 31, 2025, at 11:30 A.M. (IST) through VC/OAVM. The said Notice forms part of the Annual Report of the Company for the FY 2024-2025.

Bliss GVS Pharma Ltd.

09 Jul 2025

154.84

1.10%

Corp. Note

Bliss GVS Pharma Ltd - 506197 - Reg. 34 (1) Annual Report.

BSE India

Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find enclosed the Notice convening the 40th AGM and the Annual Report of the Company including Business Responsibility and Sustainability Report, for the financial year 2024-2025.

Bliss GVS Pharma Ltd.

08 Jul 2025

154.84

1.10%

Corp. Action

Bliss GVS Pharma Ltd - 506197 - Intimation Of Book Closure In Accordance With Regulation 42 …

BSE India

Please find enclosed herewith the Intimation for Book Closure for the purpose of the 40th Annual General Meeting of the Company.

Bliss GVS Pharma Ltd.

08 Jul 2025

154.84

1.10%

Corp. Action

Bliss GVS Pharma Ltd - 506197 - Intimation Of Record Date In Accordance With Regulation 42 …

BSE India

Please find enclosed herewith the Intimation regarding Fixation of Record Date for the payment of Final Dividend for the financial year ended March 31, 2025.

Bliss GVS Pharma Ltd.

08 Jul 2025

154.84

1.10%

Company Update

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith the Newspaper Publication regarding 40th Annual General Meeting of the Company.

Bliss GVS Pharma Ltd.

08 Jul 2025

154.84

1.10%

Company Update

Bliss GVS Pharma Ltd - 506197 - Communication To Shareholders - Intimation Of Tax Deduction On …

BSE India

Please find enclosed herewith the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.

Bliss GVS Pharma Ltd.

04 Jul 2025

154.84

1.10%

Company Update

Bliss GVS Pharma Ltd - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Please find enclosed the certificate received under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended June 30, 2025.

Bliss GVS Pharma Ltd.

02 Jul 2025

154.84

1.10%

Company Update

Bliss GVS Pharma Ltd - 506197 - Disclosure Under Regulation 30 Of Securities And Exchange Board …

BSE India

Please find attached the intimation regarding the Show Cause Notice issued by the Joint Commissioner of CGST and Central Excise, Mumbai.

Is Bliss GVS Pharma Ltd. worth buying?

168 Votes:

Buy 81.55%

Sell 8.93%

Hold 9.52%